1. Home
  2. TREE vs MYGN Comparison

TREE vs MYGN Comparison

Compare TREE & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$30.44

Market Cap

533.1M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.22

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
MYGN
Founded
1996
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.1M
444.2M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
TREE
MYGN
Price
$30.44
$5.22
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$71.25
$7.64
AVG Volume (30 Days)
193.5K
976.5K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
N/A
EPS
1.22
N/A
Revenue
$1,117,324,000.00
$771,400,000.00
Revenue This Year
$19.03
$6.86
Revenue Next Year
$7.07
$5.45
P/E Ratio
$32.34
N/A
Revenue Growth
24.12
2.33
52 Week Low
$32.65
$3.53
52 Week High
$77.35
$8.59

Technical Indicators

Market Signals
Indicator
TREE
MYGN
Relative Strength Index (RSI) 41.12 53.31
Support Level $39.05 $5.57
Resistance Level $39.74 $6.34
Average True Range (ATR) 2.23 0.32
MACD -0.82 -0.11
Stochastic Oscillator 9.01 48.57

Price Performance

Historical Comparison
TREE
MYGN

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: